The Invesco Perpetual High Income Fund aims to achieve a high level of income, together with capital growth.
Name | % Net Assets |
---|---|
GlaxoSmithKline | 7.1% |
AstraZeneca | 6.9% |
BG | 6.6% |
Reynolds American | 5.6% |
British American Tobacco | 5.5% |
Vodafone | 5.0% |
Tesco | 4.7% |
National Grid | 4.2% |
BP | 4.0% |
Imperial Tobacco | 4.0% |
Key | % Net Assets |
---|---|
GlaxoSmithKline | 7.1% |
AstraZeneca | 6.9% |
BG | 6.6% |
Reynolds American | 5.6% |
Other | 73.8% |
Date | 21-Nov-2024 |
---|---|
NAV | 101.82p |
Currency | GBP |
Change | 0.21p |
% | 0.21% |
YTD change | 6.05p |
YTD % | 6.32% |
Fund Inception | 06/02/1988 |
---|---|
Fund Manager | Neil Woodford |
TER | 1.19 (31-Dec-2013) |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | n/a |
Savings | £20 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.17% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research